Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005294 |
YEM_ID: | YEM-392 |
ID: | TCMBANKHE005294/YEM-392 |
植物拉丁名: |
|
功能与主治: | To nourish yin and engender liquid, moisten lung and clear heart./Angina pectoris, dry cough due to lung dryness, vacuity consumption with cough, fluid damage and thirst, insomnia and vexation, diabetes mellitus due to internal heat, intestinal dry and constipation, diphtheria. |
药用植物名: | 麦冬|山麦冬 |
药名: | 土麦冬 |
来源: | 云南民族药物志：第二卷 |
药用部位: | tuberoid |
使用民族: | 德昂族/水族/彝族 |
药味: | Minor cold; Minor Cool; Sweet |
经络: | Lung; Stomach; Heart |
临床特征: | 1. Relieving leucopenia in mice induced by cyclophosphamide and radiation sickness in dogs.2. Increasing anoxia tolerance in experimental animals under atmospheric pressure.3. Increasing coronary flow and improving myocardial contractility in guinea-pigs. |
治疗类型: | 补虚 |
TCM_ID_id: | 2522 |
TCMSP_id: | 500 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000064 | diosgenin | AKOS025402315; MolPort-028-744-580; (25R)-5-Spirosten-3beta-ol; 3beta-Hydroxy-5-spirostene; nitogenin; NSC 226132; Spirost-5-en-3-ol, (3beta,25S)-; diosgenin ; AC-8024; 512-04-9; 22-epi-Yamogenin; C08898; D1634_SIGMA | C27H42O3 | 414.62 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C)OC1 |
| TCMBANKIN001079 | ophiopogonin b | C46H72O17 | 897.05 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(C(CC(C6)O)OC7C(C(C(C(O7)C)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)C)OC1 | |
| TCMBANKIN001171 | orchinol | C16H16O3 | 256.3 g/mol | COC1=CC2=C(C3=C(CC2)C=C(C=C3)O)C(=C1)OC | |
| TCMBANKIN001838 | 2,5,8,11,14-pentaoxahexadecan-16-ol | C11H24O6 | 252.3 g/mol | COCCOCCOCCOCCOCCO | |
| TCMBANKIN002907 | guanosine | Guanosine, hydrate; s3068; CTK0F0492; Guanosine hydrate (1:1); 2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihyd; YCHNAJLCEKPFHB-GWTDSMLYSA-N; Guanosine, hydrate (1:1); Z-4761; SCHEMBL555106; AK645793; 1143525-19-2; MolPort-003-935-435; guanosine-hydrate; AK607682; 2-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one hydrate(1:x); 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one hydrate; 2451AH; 294B1373-E8C3-442D-8240-D7EA2650B160; AKOS030573276; 141433-61-6; ro-6H-purin-6-one hydrate; 2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one hydrate; Guanosine Hydrate; B3678 | C10H13N5O5 | 283.24 | C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(NC2=O)N |
| TCMBANKIN004398 | ophiopogon a | C44H70O18 | CC1CCC2(C(C3(C(O2)CC4(C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)OC8C(C(C(CO8)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)O)O)C)OC1 | ||
| TCMBANKIN009493 | 5,7,2'-trihydroxy-8,6'-dimethoxyflavone | SCHEMBL8814605; NP-016425; AC1NT15I; MCULE-7679878342; 5,7-dihydroxy-2-(2-hydroxy-6-methoxyphenyl)-8-methoxychromen-4-one; 2-(2-Hydroxy-6-methoxyphenyl)-5,7-dihydroxy-8-methoxy-4H-1-benzopyran-4-one; LMPK12111310; 5,7,2'-Trihydroxy-8,6'-dimethoxyflavone | C17H14O7 | 330.29 g/mol | COC1=CC=CC(=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)OC)O |
| TCMBANKIN012618 | methyl ophiopogonanone a | methylophiopogonanone a | C19H18O6 | 342.34 | CC1=C(C(=C2C(=C1O)C(=O)C(CO2)CC3=CC4=C(C=C3)OCO4)C)O |
| TCMBANKIN018649 | 6-allyl-7-(3,4-dimethoxyphenyl)-2,3-dimethoxy-8-methyl-tricyclo[4.2.0.02,8]oct-3-en-5-one | C22H26O5 | CC12C(C3(C1C2(C(=CC3=O)OC)OC)CC=C)C4=CC(=C(C=C4)OC)OC | ||
| TCMBANKIN019606 | methyl ophiopogonanone b | methylophiopogonanone b | C19H20O5 | 328.36 | CC1=C(C(=C2C(=C1O)C(=O)C(CO2)CC3=CC=C(C=C3)OC)C)O |
| TCMBANKIN021776 | methylophiopogonone b | methy-lophiopogonone b | C19H18O5 | 326.34 | CC1=C(C(=C2C(=C1O)C(=O)C(=CO2)CC3=CC=C(C=C3)OC)C)O |
| TCMBANKIN023187 | (25s)-samogenin 3-o-β-d-glucopyranosyl(1→2)-β-d-galactopyranoside | ||||
| TCMBANKIN023378 | methylophiopogonone a | methy-lophiopogonone a | C19H16O6 | 340.33 | CC1=C(C(=C2C(=C1O)C(=O)C(=CO2)CC3=CC4=C(C=C3)OCO4)C)O |
| TCMBANKIN024288 | 2,5,7-trihydroxy-6,8-dimethyl-3-(4'-methoxy-benzyl)chroman-4-one | C19H20O6 | 344.4 g/mol | CC1=C(C(=C2C(=C1O)C(=O)C(C(O2)O)CC3=CC=C(C=C3)OC)C)O | |
| TCMBANKIN027056 | 5, 7-dihydroxy- 6, 8- dimethylflavanone | C17H16O4 | 284.31 g/mol | CC1=C(C(=C2C(=C1O)C(=O)CC(O2)C3=CC=CC=C3)C)O | |
| TCMBANKIN031453 | ophiopogonone b | C18H16O5 | 312.32 | CC1=C(C2=C(C=C1O)OC=C(C2=O)CC3=CC=C(C=C3)OC)O | |
| TCMBANKIN034045 | ophiopogon b | C50H80O23 | CC1CCC2(C(C3(C(O2)CC4(C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)O)O)OC9C(C(C(CO9)O)O)O)OC2C(C(C(C(O2)C)O)O)O)C)C)O)O)C)OC1 | ||
| TCMBANKIN036907 | ophiopogonin D | C44H70O16 | 855 | C1([H])([H])[C@]([H])(O[C@@]2([H])[C@]([H])(O[C@]([H])(O[C@@]3([H])C([H])([H])[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])[C@@]([H])(O[C@@]4([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(O[H])C([H ])([H])O4)[C@@]([H])(O[H])[C@@]([H])(C([H])([H])[H])O2)[C@]5(C([H])([H])[H])C(=C([H])C([H])([H])[C@]6([H])[C@]5([H])C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@@]7([H])[C@]([H])(O[C@@]8(OC([H])([H] )[C@]([H])(C([H])([H])[H])C([H])([H])C8([H])[H])[C@@]7([H])C([H])([H])[H])C9([H])[H])[C@@]69[H])C([H])([H])[C@]1([H])O[H] | |
| TCMBANKIN037242 | ophiopogonanone E | C19H20O7 | 360.358 | c1(O[H])c(OC([H])([H])[H])c(OC([H])([H])[C@]([H])(C([H])([H])c2c([H])c([H])c(OC([H])([H])[H])c([H])c2O[H])C3=O)c3c(O[H])c1C([H])([H])[H] | |
| TCMBANKIN037277 | Oleanolic acid | Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid | C30H48O3 | 457 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
| TCMBANKIN037440 | Uridine | URI; SBB000838; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]pyrimidine-2,4-dione; SMR000058222; MLS000069625; AIDS185903; 1-beta-D-Ribofuranosyluracil; NSC 20256; 1-[(2R,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-3H-PYRIMIDINE-2,4-DIONE; SY005419; AKOS015960347; MolPort-005-932-481; AC-10519; araU; 12693-39-9; ZINC02583633; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; AB0012293; Uracil-1-beta-D-ribofuranoside; SCHEMBL890304; NCGC00142368-01; C00299; 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione; BG00950366; U3750_SIGMA; Uridine, labeled with tritium; AI3-52690; AIDS-185903; U3003_SIGMA; AS-12665; Uracil, 1-beta-D-ribofuranosyl-; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]pyrimidine-2,4-quinone; 21231-59-4; U6381_SIGMA; SMP1_000029; CHEBI:16704; 68184-15-6; 1-((2r,5r)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1h-pyrimidine-2,4-dione; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione; EINECS 200-407-5 | 244.201 | ||
| TCMBANKIN038010 | Ophiopogonoside A | 418.5 g/mol | |||
| TCMBANKIN038869 | Ophiopogonanone D | 370.353 | |||
| TCMBANKIN040282 | Borneol-2-O-α-L-arabinofuranosyl(1→6)-β-D-glucopyranoside | ||||
| TCMBANKIN040354 | borneol-2-o-β-d-apiofuranosyl(1→6)-β-d-glucopyranoside | C21H36O10 | CC1(C2CCC1(C(C2)OC3C(C(C(C(O3)COC4C(C(CO4)(CO)O)O)O)O)O)C)C | ||
| TCMBANKIN043147 | Ophiopogonone A | 326.3 | |||
| TCMBANKIN044067 | ophiopogonanone F | C20H22O7 | 374.384 | c1(O[H])c(OC([H])([H])[H])c(OC([H])([H])[C@]([H])(C([H])([H])c2c([H])c([H])c(OC([H])([H])[H])c([H])c2O[H])C3=O)c3c(OC([H])([H])[H])c1C([H])([H])[H] | |
| TCMBANKIN044862 | ophiopogonanone a | C18H16O6 | 328.32 | CC1=C(C2=C(C=C1O)OCC(C2=O)CC3=CC4=C(C=C3)OCO4)O | |
| TCMBANKIN044917 | Ruscogenin 1-O-sulfate | ||||
| TCMBANKIN045250 | ophiopogonanone b | C18H18O5 | 314.3 g/mol | CC1=C(C2=C(C=C1O)OCC(C2=O)CC3=CC=C(C=C3)OC)O | |
| TCMBANKIN045744 | ophiogenin-3-o-α-l-rhamnopyranosyl(1→2)-β-d-glucopyranoside | C39H62O14 | CC1CCC2(C(C3(C(O2)CC4(C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)O)O)C)OC1 | ||
| TCMBANKIN046133 | Ophiopogonin D' | 855 g/mol | |||
| TCMBANKIN046486 | jasmololone | C11H16O2 | 180.24 g/mol | CCC=CCC1=C(C(CC1=O)O)C | |
| TCMBANKIN046924 | Ophiopogonanone C | 356.3 g/mol | |||
| TCMBANKIN046963 | Ophiopogonin C' | 722.9 g/mol | |||
| TCMBANKIN047203 | ophiopogonin a | C41H64O13 | 764.94 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(C(CC(C6)O)OC7C(C(C(C(O7)C)O)O)OC8C(C(C(C(O8)C)O)OC(=O)C)O)C)C)C)OC1 | |
| TCMBANKIN048426 | Ruscogenin | C27H42O4 | 431 | C1([H])([H])[C@@]([H])(O[H])[C@@]2(C([H])([H])[H])C(=C([H])C([H])([H])[C@]3([H])[C@]2([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]4([H])[C@]([H])(O[C@@]5(OC([H])([H])[C@]([H])(C([H])([H])[H])C ([H])([H])C5([H])[H])[C@@]4([H])C([H])([H])[H])C6([H])[H])[C@@]36[H])C([H])([H])[C@@]1([H])O[H] | |
| TCMBANKIN049610 | Ophiopogonone C | 354.31 | |||
| TCMBANKIN050053 | Borneol-2-O-β-D-glucopyranoside | ||||
| TCMBANKIN057944 | 2-(hydroxymethyl)serine;2-Hydroxymethylserine | C03059; 2-amino-3-hydroxy-2-methylol-propionic acid; 2-amino-3-hydroxy-2-(hydroxymethyl)propanoic acid; alpha-Hydroxymethylserine | C4H9NO4 | 135.12 | C(C(CO)(C(=O)O)N)O |
| TCMBANKIN058195 | n-trans-p -coumaroyloctopamine | n-[β-hydroxy-β-(4-hydroxyphenyl)]ethyl-4-hydroxy cinnamide | C17H17NO4 | 299.32 | C1=CC(=CC=C1C=CC(=O)NCC(C2=CC=C(C=C2)O)O)O |
| TCMBANKIN058450 | ADO | nchembio.2007.56-comp13; CHEBI:16335; Bio1_000437; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; AIDS-001224; 9beta-D-Ribofuranosyladenine; BSPBio_001796; beta-Adenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; beta-D-Ribofuranoside, adenine-9; D00045; 46969-16-8; SDCCGMLS-0003108.P003; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; NSC 7652; Bio1_001415; Adenosine (JAN/USP); Spectrum2_001257; Spectrum3_000288; Adenosine, homopolymer; ADN; Caswell No. 010B; Adenocard; C00212; SR 96225; Adenocard (TN); EINECS 200-389-9; KBio3_001296; 9H-Purin-6-amine, 9beta-D-ribofuranosyl-; Polyadenosine; beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-; (2R,3R,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; MLS000069638; AI3-52413; 9-beta-D-Ribofuranosidoadenine; A9251_SIGMA; Adenoscan (TN); Bio1_000926; ZINC02169830; CCRIS 2557; NCGC00023673-05; Ade-Rib; nchembio706-5; 30143-02-3; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; Adenosin [German]; NSC 627048; SMR000058216; 9-beta-D-Ribofuranosyladenine; SPBio_001194; beta-D-Adenosine; Adenosine [USAN:BAN]; Polyriboadenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS001224; 6-Amino-9beta-D-ribofuranosyl-9H-purine; ST009496; Adenoscan; A4036_SIGMA; SPECTRUM1500107; 46946-45-6;SCHEMBL170902; adenosine ; AKOS015960342; AC-5504; BC200893; Adenosine;adenosine;adeninenucleoside | C10H13N5O4 | 267.24 g/mol | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N |
| TCMBANKIN059679 | 6-aldehydoisoophiopogone b | C19H16O6 | 340.332 | CC1=C(C(=C(C2=C1OC=C(C2=O)CC3=CC=C(C=C3)OC)O)C=O)O | |
| TCMBANKIN059680 | 6-aldehydo-isoophipogonone a | C19H14O7 | 354.315 | CC1=C(C(=C(C2=C1OC=C(C2=O)CC3=CC4=C(C=C3)OCO4)O)C=O)O | |
| TCMBANKIN059832 | methyl beta-orcinol caroxylate | C10H12O5 | CC1=CC(=C(C(=C1C(=O)OC)O)C=O)O | ||
| TCMBANKIN060488 | ophiopogonin d | C44H70O16 | 855.02 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(C(CC(C6)O)OC7C(C(C(C(O7)C)O)OC8C(C(C(CO8)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1 | |
| TCMBANKIN060489 | 25(s)-ruscogenin 1-o-α-l-rhamnopy-ranosyl-(1→2)-β-d-xylopyranoside | C38H60O12 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(C(CC(C6)O)OC7C(C(C(CO7)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)C)OC1 | ||
| TCMBANKIN060493 | progenin iii | C39H62O12 | 722.9 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)C)OC1 | |
| TCMBANKIN060566 | β-patchoulene | C15H24 | 204.35 | CC1CCC2=C1CC3CCC2(C3(C)C)C | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060680 | stigmasterol-3-glucoside | C35H58O6 | 574.83 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN061574 | feruloyltyramine | n- cis-feruloyltyramine; NP-001984; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; NCGC00169550-01; N-Trans-Feruloyl Tyramine; Moupinamide, >=95% (LC/MS-ELSD); 66648-43-9; Alfrutamide; trans-N-Feruloyltyramine; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; N-Feruloyltyramine; ZINC901461; MEGxp0_000693; Feruloyltyramine; Moupinamide; BRD-K98045316-001-01-0; MolPort-001-740-847; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; MCULE-4768764740; n-trans-feruloyl-tyramine; W1092; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; ACon1_001233; N-trans-Feruloyltyramine; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; CHEMBL206555; 65646-26-6; n- trans-feruloyltyramine; N-Transferuloyl Tyramine; MFCD17214811; AKOS025287596; CHEBI:17818; C02717; AC1NQX6M; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; CHEBI:17818; 3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS113439; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; N-trans-Feruloyltyramine; C02717; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; N-Feruloyltyramine; 65646-26-6; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS-113439; 66648-43-9; Feruloyltyramine; moupinamide; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; ACon1_001233; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; MEGxp0_000693; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-, (2Z)-; 80510-09-4; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; Moupinamide; n-trans-feruloyltyramine; N-E-feruloyl tyramine; n-cis-feruloyltyramine | C18H19NO4 | 313.3 g/mol | COC1=C(C=CC(=C1)C=CC(=O)NCCC2=CC=C(C=C2)O)O |
| TCMBANKIN061650 | 5-hydroxy-7,8-dimethoxy flavanone | 5-Hydroxy-7,8-dimethoxyflavone; SCHEMBL6070206; DTXSID80189221; 7-O-Methylwogonin; MolPort-001-741-309; BRD-K93000037-001-01-8; ACon1_000806; LMPK12111332; W2720; 4H-1-Benzopyran-4-one,5-hydroxy-7,8-dimethoxy-2-phenyl-; ZINC5998918; CTK4H5203; 5-hydroxy-7,8-dimethoxy-2-phenyl-4h-chromen-4-one; 4H-1-Benzopyran-4-one, 5-hydroxy-7,8-dimethoxy-2-phenyl-; 7-O-Methylwogonin, analytical standard; 5-hydroxy-7,8-dimethoxy-2-phenylchromen-4-one; Ambotz3570-62-5; 4CN-2462; CHEMBL2235239; FT-0698311; AKOS032948839; Moslosooflavone; AC1L4MKS; NCGC00169341-01; 3570-62-5; AC1Q6AK7 | C17H16O5 | 300.31 | COC1=C(C2=C(C(=C1)O)C(=O)C=C(O2)C3=CC=CC=C3)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab